Real-World Evidence Needs for Treatment Sequence Disease Modelling in Refractory Inflammatory Bowel Disease

被引：0
|
作者：
Kodjamanova, P. [1 ]
Sanon, M. [2 ]
Dimova, M. [3 ]
Wu, E. [2 ]
Atanasov, P. [4 ]
机构：
[1] Amaris Consulting, Real World Evidence, London, England
[2] Janssen Global Serv, Global Market Access, Raritan, NJ USA
[3] Janssen Global Serv, HTA Modelling, Horsham, PA USA
[4] Amaris Consulting, Real World Evidence, Barcelona, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2025年 / 19卷
关键词：
D O I：
10.1093/ecco-jcc/jjae190.1437
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P1263
引用
收藏
页码：i2288 / i2288
页数：1
相关论文
共 50 条
  • [41] Pregnancy in Inflammatory Bowel Disease: Data from a Real-World Cohort in Germany
    Ayoub, Mousa
    Muzalyova, Anna
    Ebigbo, Alanna
    Nagl, Sandra
    Roemmele, Christoph
    Classen, Johanna
    Wanzl, Julia
    Fleischmann, Carola
    Ayoub, Sami
    Tadic, Vidan
    Schlottmann, Jakob
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (24)
  • [42] Estimation of patients affected by inflammatory bowel disease potentially eligible for biological treatment in a real-world setting
    Degli Esposti, Luca
    Perrone, Valentina
    Sangiorgi, Diego
    Saragoni, Stefania
    Dovizio, Melania
    Caprioli, Flavio
    Rizzello, Fernando
    Daperno, Marco
    Armuzzi, Alessandro
    DIGESTIVE AND LIVER DISEASE, 2024, 56 (01) : 29 - 34
  • [43] Real-world assessment of biological treatment of inflammatory bowel disease at an Austrian Referral Centre: the ULTIMATE study
    Groechenig, H. P.
    Walter, E.
    Redl, A.
    Bresztowanszky, M.
    Steidl, K.
    Siebert, F.
    Novacek, G.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S266 - S267
  • [44] Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study
    Celine Miyazaki
    Yutaka Ishii
    Natalia M. Stelmaszuk
    Clinical Rheumatology, 2022, 41 : 741 - 755
  • [45] Osteoporosis, osteopenia, and inflammatory bowel disease: lessons from a real-world study
    Pellicano, Rinaldo
    Ribaldone, Davide G.
    POLISH ARCHIVES OF INTERNAL MEDICINE-POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ, 2018, 128 (7-8): : 411 - 413
  • [46] Real-world data on switching from intravenous to subcutaneous vedolizumab treatment in patients with inflammatory bowel disease
    Bergqvist, Viktoria
    Holmgren, Johanna
    Klintman, Daniel
    Marsal, Jan
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (11) : 1389 - 1401
  • [47] Iron deficiency anemia impacts disease progression and healthcare resource consumption in patients with inflammatory bowel disease: a real-world evidence study
    Fiorino, Gionata
    Colombel, Jean-Frederic
    Katsanos, Kostas
    Mearin, Fermin
    Stein, Juergen
    Andretta, Margherita
    Antonacci, Stefania
    Arenare, Loredana
    Citraro, Rita
    Dell'Orco, Stefania
    Esposti, Luca Degli
    de Arellano Serna, Antonio Ramirez
    Morin, Neige
    Koutroubakis, Ioannis E.
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [48] Correction to: Disease burden and treatment sequence of polymyositis and dermatomyositis patients in Japan: a real-world evidence study
    Celine Miyazaki
    Yutaka Ishii
    Natalia M. Stelmaszuk
    Clinical Rheumatology, 2022, 41 : 2619 - 2619
  • [49] Real-World Persistency for Inflammatory Bowel Disease Biologics Using Patient Registry Data
    Goss Sawhney, Tia
    Dobes, Angela
    O'Charoen, Sirimon
    CROHNS & COLITIS 360, 2023, 5 (04)
  • [50] REAL-WORLD PRESCRIPTION DRUG UTILIZATION AND COSTS OF BIOLOGICAL THERAPIES IN INFLAMMATORY BOWEL DISEASE
    Yu, Helen
    Park, K. T.
    GASTROENTEROLOGY, 2017, 152 (05) : S791 - S791
12345